The Effect of Theophylline in the Treatment of Bronchiectasis
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
Theophylline was well recommended in the treatment of chronic obstructive pulmonary disease
(COPD) and asthma. However, there is no supporting evidence for their efficacy in the
treatment of bronchiectasis. Our hypothesis is that theophylline will play a role in
bronchiectasis. Our purpose is to examine the efficacy and safety of 24 weeks treatment with
theophylline in subjects with non-cystic fibrosis bronchiectasis.
Phase:
Phase 4
Details
Lead Sponsor:
The First Affiliated Hospital of Guangzhou Medical University